Brief: Vaxart Q2 Net Income USD -13.494 Million
06/08/2026 21:06
BRIEF-Vaxart Q2 Net Income USD -13.494 Million Aug 06 (Reuters) - Vaxart Q2 revenue USD 27.185 million.
- Q2 operating income USD -13.172 million
- Q2 pretax profit USD -13.465 million
- Q2 basic EPS USD -0.06
- Q2 operating expenses USD 40.357 million
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts